MRNA

195.0002.17%
JA

Juan Andres

Chief Operating Officer

Mr. Juan Andres serves as Independent Director of Evelo Biosciences, Inc. since December 2019. Mr. Andres served as President of Strategic Partnerships & Enterprise Expansion at Moderna, Inc. (Formerly known as, Moderna Therapeutics, Inc.) since October 2022 until May 2023 and had been its Chief Technical Operations & Quality Officer since August 2017 until October 2022. He previously served as Senior Vice President of Late Stage Technical Development & Manufacturing at Moderna, Inc. since August 3, 2017. From 2005 to 2017, Mr. Andres served in several leadership positions at Novartis AG. Mr. Andres served as Global Head Technical Operations (Manufacturing and Supply) at Novartis, has joined the Novartis as Senior Vice President of Late Stage Technical Development & Manufacturing (beyond human proof of concept, or hPOC). Mr. Andres was previously the Global Head of Technical Operations (Manufacturing and Supply Chain) for over 25,000 Novartis employees across all of its divisions from January 2013 to June 2017. In this role, he had responsibility for all of Novartis’ manufacturing sites and related support functions and technologies worldwide, overseeing small molecules drug substance and drug product, as well as biologics drug substance, drug product and technical development. Mr. Andres’ previous roles at Novartis included Global Head of Technical Research & Development and Global Pharmaceutical Operations Head of TechOps from August 2005 to January 2013. Mr. Andres has extensive experience in pharmaceutical manufacturing, supply chain and technical research. Mr. Andres served as Head of Pharma Quality Assurance at Novartis Vaccines & Diagnostics since April 2009. He served as Head of Novartis Group Quality at Novartis Vaccines and Diagnostics, Inc. and Novartis AG since February 1, 2010. Prior to 2005, Mr. Andres spent 18 years at Eli Lilly Company, a global healthcare company, serving in a variety of leadership positions, including Vice President Pharmaceutical Manufacturing & Devices in a variety of senior manufacturing, production, and quality roles in the United States, Puerto Rico, United Kingdom, and Spain. Mr. Andres serves as Director of Ring Therapeutics. Mr. Andres has been a Director of Avantor, Inc. since September 2019. Mr. Andres holds a Masters’ Degree in Pharmacy from Alcala de Henares University in Madrid, Spain and has completed an advanced development program at the London Business School.

Positions